Homepage > Company > Media > Pharma News > 2021 > Ebola vaccination campaign begins in Democratic Republic of Congo

Ebola vaccination campaign begins in Democratic Republic of Congo

KINSHASA (Reuters) - An Ebola vaccination campaign has begun in the city of Butembo, in eastern Democratic Republic of Congo, the World Health Organization (WHO) said in a tweet on Monday.

Health workers at Matanda health centre, where the first Ebola patient was treated, were the first to be vaccinated, the WHO said.

Congo has confirmed four cases of Ebola since a resurgence of the virus was announced on Feb. 7 in Butembo, the epicentre of a previous outbreak that was declared over last June.

On Friday, 1,200 doses of Ebola vaccine and cold chain equipment arrived in the city, according to the WHO.

Separately, the West African country of Guinea declared a new Ebola outbreak on Sunday, with seven confirmed cases and three deaths.

The Ebola virus causes severe vomiting and diarrhoea and is spread through contact with body fluids. The new vaccines have greatly improved survival rates in recent years.

FEBRUARY 15, 2021

https://www.reuters.com/

Read also

Spinogenix’s ALS hopeful to advance to registrational trial

Spinogenix’s first-in-class ALS treatment, SPG302 has been shown to slow disease progression in 82% of patients during a Phase IIa study.

FDA Approves First Treatment for Rare Thymidine Kinase 2 Deficiency

Thymidine kinase 2 deficiency (TK2d) is an ultra-rare (1.64 cases per 1,000,000 people) often fatal, genetic mitochondrial disease characterized by progressive and severe muscle weakne...

Cencora

Cencora to invest $1bn in US pharma distribution network

Celltrion

Celltrion Signs Licensing Deal with U.S. Kaigene for Two Antibody Drug Candidates